| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/200 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | HMG CoA synthase; HMGCS2;;HMGCS2 |
| WB Predicted band size | Calculated MW: 57 kDa ; Observed MW: 50 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | A synthesized peptide derived from human HMGCS2 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是3篇与HMGCS2抗体相关的文献摘要概览：
1. **"HMGCS2-mediated ketogenesis suppresses hepatocellular carcinoma via a feedback loop with histone acetyltransferase KAT5"**
*作者：Zhang et al. (2023)*
摘要：研究通过Western blot和免疫组化使用HMGCS2抗体，揭示了HMGCS2在肝癌中通过调控酮体生成抑制肿瘤的机制，并发现其与KAT5的反馈调控关系。
2. **"Immunohistochemical detection of HMGCS2 in colorectal cancer: Association with metabolic reprogramming and prognosis"**
*作者：Tanaka et al. (2021)*
摘要：利用特异性HMGCS2抗体分析结直肠癌组织，发现HMGCS2低表达与患者预后不良相关，提示其在癌细胞代谢重编程中的作用。
3. **"HMGCS2 regulates PPARα activity to maintain metabolic flexibility in starved mice"**
*作者：Ramos-Pamplona et al. (2020)*
摘要：通过免疫荧光和Western blot(使用HMGCS2抗体)，证明饥饿状态下小鼠肝脏HMGCS2通过激活PPARα维持代谢适应性，为代谢疾病研究提供依据。
4. **"Antibody-based profiling of mitochondrial enzymes in neurodegenerative disorders"**
*作者：Smith et al. (2019)*
摘要：研究验证了HMGCS2抗体在脑组织线粒体中的特异性，发现阿尔茨海默病患者脑区HMGCS2表达下降，提示酮体代谢障碍可能与神经退行性病变相关。
注：以上文献名为模拟概括，实际研究中需根据具体论文调整。建议通过PubMed或Google Scholar以“HMGCS2 antibody”为关键词检索最新文献。
The HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) antibody is a critical tool for studying the mitochondrial enzyme HMGCS2. which plays a central role in ketogenesis. HMGCS2 catalyzes the first rate-limiting step in ketone body production, converting acetyl-CoA and acetoacetyl-CoA into HMG-CoA. This enzyme is predominantly expressed in the liver and, to a lesser extent, in intestinal and other tissues, where it supports energy homeostasis during fasting or low-carbohydrate conditions by generating ketones as alternative fuels for the brain, heart, and skeletal muscles.
HMGCS2 antibodies are widely used in research to investigate metabolic disorders, such as diabetes, obesity, and fatty liver disease, where dysregulated ketogenesis is implicated. They enable the detection and quantification of HMGCS2 protein levels via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Recent studies also explore HMGCS2's role in cancer, as some tumors exploit ketone metabolism for growth. Additionally, these antibodies aid in understanding developmental biology, as HMGCS2 is essential for neonatal survival and brain development.
Commercial HMGCS2 antibodies are typically raised against specific epitopes of human or murine HMGCS2. with validation in knockout models to ensure specificity. Their applications extend to diagnostic research and therapeutic target validation, highlighting their importance in advancing metabolic and oncological studies.
×
